First ‘targeted’ treatment for small cell lung cancer shows promise

Small cell lung cancer (SCLC) is an aggressive disease that is difficult to treat and is frequently only diagnosed when it has spread to other parts of the body (metastasized). Five-year survival rates in SCLC, which accounts for about 14% of all lung cancers, are very low, at only six percent. But now US researchers have two novel findings.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1MYFlHo